Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639297 · ClinicalTrials.gov registry record · NA
NeuroVision vs Standard Neuromonitoring
A NA study of Neurologic Deficits, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT04639297 is a NA study of Neurologic Deficits that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 148 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04639297, a NA study of Neurologic Deficits, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.
Conditions Studied
Interventions
- DEVICE NeuroVision® IONM
- DEVICE Hospital Based IONM
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2027-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04639297
The ClinicalTrials.gov registry entry for NCT04639297 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurologic Deficits appearing as the primary indexed condition, and to 2 interventions - of which NeuroVision® IONM is the first listed.
NCT04639297 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04639297 about?
NCT04639297 is a clinical study titled "NeuroVision vs Standard Neuromonitoring". The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM ...
What is the current status of trial NCT04639297?
This trial is currently recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2020-09-28. Estimated completion is 2027-06-20.
What conditions does trial NCT04639297 study?
This clinical trial studies the following conditions: Neurologic Deficits.
What interventions are being tested in trial NCT04639297?
The interventions under investigation include: NeuroVision® IONM (DEVICE), Hospital Based IONM (DEVICE).
Who is sponsoring clinical trial NCT04639297?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04639297 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurologic Deficits
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.